AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Hazards of the FDA.(Between The Lines)(Brief Article)

The New American

| May 17, 2004 | Hoar, William P. | COPYRIGHT 2004 American Opinion Publishing, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ITEM: Over-the-counter drugs aren't risk-free, the April 13 HealthDay reported. Too much acetaminophen, the active ingredient in many medicines, "can lead to liver damage, and even death, the U.S. Food and Drug Administration warns. So the agency advises consumers to avoid taking multiple medications that contain the same active ingredient together ..." Accordingly, the "FDA has launched an educational campaign to promote the safe use of over-the-counter pain relievers and fever reducers."

BETWEEN THE LINES: This seemingly benign suggestion just hints at the FDA's influence. The agency regulates products worth a staggering $1 trillion annually, about 25 cents of every consumer dollar, notes former FDA official Henry I. Miller.

Others pay for mistakes generated by the agency's risk-adverse bureaucrats, who would rather say "no" than allow a drug on the market that might distress someone, somewhere, sometime. For example, ...

Related articles from newspapers, magazines, journals, and more
FDA OKs Avastin for the Most Common Type of Kidney Cancer
Newspaper article from: Wireless News August 7, 2009 700+ words
...News 08-07-2009 FDA OKs Avastin for the Most Common Type of Kidney Cancer Type: News Genentech...of ten people with kidney cancer have renal cell carcinoma...Avastin in Metastatic Kidney Cancer This FDA approval is based on...
FDA APPROVES AVASTIN FOR THE MOST COMMON KIDNEY CANCER.
Newspaper article from: Biotech Business September 1, 2009 700+ words
...Drug Administration (FDA) approved Avastin...most common type of kidney cancer. According to the...of ten people with kidney cancer have renal cell carcinoma...Avastin in Metastatic Kidney Cancer This FDA approval is based on...
FDA Approves Avastin for the Most Common Type of Kidney Cancer.
Newspaper article from: Angiogenesis Weekly August 21, 2009 700+ words
...Drug Administration (FDA) approved Avastin...most common type of kidney cancer. According to the...of ten people with kidney cancer have renal cell carcinoma...Avastin in Metastatic Kidney Cancer This FDA approval is based on...
FDA OKs Avastin for the Most Common Type of Kidney Cancer.
Magazine article from: Health & Beauty Close-Up August 6, 2009 700+ words
...Drug Administration (FDA) approved Avastin...most common type of kidney cancer. According to the...of ten people with kidney cancer have renal cell carcinoma...Avastin in Metastatic Kidney Cancer This FDA approval is based on...
FDA approves new treatment for advanced kidney cancer.
Press release article from: M2 Presswire December 21, 2005 700+ words
M2 PRESSWIRE-21 December 2005-US FDA: FDA approves new treatment for advanced kidney cancer(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:20122005 The Food and Drug Administration (FDA) today approved Nexavar (sorafenib tosylate...
FDA Approves New Treatment for Advanced Form of Kidney Cancer.
Newspaper article from: Angiogenesis Weekly November 6, 2009 700+ words
...Drug Products in the FDA's Center for Drug Evaluation...other drugs approved for kidney cancer and their approval dates...Inquiries: 888-INFO-FDA Keywords: Angiogenesis...Drugs, Everolimus, FDA, Kidney Cancer, Monoclonal Antibodies...
FDA Approves New Drug for Advanced Kidney Cancer.
Press release article from: M2 Presswire May 31, 2007 700+ words
...PRESSWIRE-31 May 2007-US FDA: FDA Approves New Drug for Advanced Kidney Cancer(C)1994-2007 M2 COMMUNICATIONS...advances in the battle against kidney cancer," said Steven Galson...H., director of the FDA's Center for Drug Evaluation...
FDA questions safety of Glaxo kidney cancer drug
News wire article from: AP Online MATTHEW PERRONE October 1, 2009 700+ words
...an experimental kidney cancer drug from GlaxoSmithKline...pills for advanced kidney cancer, a rare but deadly...posted online, FDA reviewers noted...options for advanced kidney cancer, which killed...since 2005, the FDA has approved five...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA